Takeda

News

NICE backs NHS use of Takeda’s Adcetris for rare blood cance...

Takeda’s antibody-drug conjugate Adcetris can now be routinely available on the NHS to patients with a rare form of non-Hodgkin lymphoma (NHL), says NICE.

News

Takeda to make $200m loss after Novartis' dry-eye drug hits ...

Novartis’ decision to withdraw a European filing for its dry-eye drug Xiidra is to have a knock-on effect on Takeda, causing it to make a loss of $200 million this quarter.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

After Celgene deal, BMS shoots up pharma market cap rankings

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalDat

News

Celltrion buys drug portfolio from Takeda, ventures into chr...

South Korea’s Celltrion has made its first major acquisition, buying a portfolio of drugs including diabetes and hypertension drugs from Takeda that will expand its expertise with small mol

News

Takeda posts surprise profit a year after Shire mega-merger

Japan’s Takeda has posted a surprise profit after its $59 billion merger with Shire just over a year ago, as the company shakes off the huge debts it incurred to get the deal done.

News

Takeda to sell European OTC business to cut debts

Japan’s Takeda has said it would sell up to $670 million of over-the-counter (OTC) drug operations in Europe to cut its debts.

NICE backs NHS use of Takeda’s Adcetris for rare blood cance...

Takeda to make $200m loss after Novartis' dry-eye drug hits ...

After Celgene deal, BMS shoots up pharma market cap rankings

Celltrion buys drug portfolio from Takeda, ventures into chr...

Takeda posts surprise profit a year after Shire mega-merger

Takeda to sell European OTC business to cut debts

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Takeda

Editor's Picks